|

Rabies in Bali, Indonesia

An outbreak of rabies in dogs has been ongoing in Bali, Indonesia, since November 2008. As of November 1, 2011, more than 100 people have died from rabies in Bali since the outbreak began. Human and animal rabies cases have been confirmed near popular tourist destinations throughout the island. Despite systematic efforts to control rabies in dogs, the outbreak is continuing on the island.  GeoSentinel data indicate that the number of requests for rabies postexposure prophylaxis has increased among travelers returning from Bali since May 2008.

 

Similar Posts

  • Nuclear Emergency In Japan

    Authorities in Japan have declared a nuclear emergency following the loss of power to ten nuclear reactor units in three separate nuclear power plants (Onagawa, Fukushima Daiichi and Fukiushima Daini). The cooling systems at both Daiichi and Daini experienced problems. Daiichi experienced explosions in three units (Nos. 1, 2 and 3) and a fire has…

  • 2012 Europe Measles Outbreak

    A new report today describing the large scale of measles outbreaks in European countries underscores their serious public health and economic implications. The World Health Organization European Region’s report emphasizes the urgent actions European countries should take to prevent measles outbreaks in 2012 and beyond, particularly with the approaching high season for measles transmission.  The…

  • Canada Public Health Agency Reports Measles in Quebec

      Since late January 2015, the Public Health Agency of Canada has confirmed 139 cases of measles.  This is a significant increase over the average incidence rate.  Cases have been primarily reported from a non-immunizing religious community in Lanaudiere Region, Quebec.  A case has been linked to the outbreak in Disneland (Anaheim, California).  Eighteen cases…

  • Shingles Vaccine

      It estimated that less than 2 out of 10 Americans aged 60 and older are getting vaccinated against shingles.  Efforts for recommended innoculation are being increased in the US. Merck’s shingles vaccine Zostavax is recommended for all people aged 60 and older, and in 2011 was cleared for usage in all those 50 and older. Shingles becomes…